Target intelligence / Profile preview

Acetylcholine receptor subunit acr-23 (ACR-23) (ACR-23)

Target
ACR-23
Molecular classification
Ion channel, Nicotinic acetylcholine receptor, Receptor
01

Overview

Acetylcholine receptor subunit acr-23 (ACR-23), also known as Monepantel-sensitive receptor 1 (MPTL-1), is a critical component of a nematode-specific nicotinic acetylcholine receptor (nAChR) (Kaminsky et al., 2008, Nature). It belongs to the DEG-3 subfamily of ligand-gated ion channels, which are phylogenetically distinct from the nAChRs found in vertebrate hosts (Rufener et al., 2009, Molecular and Biochemical Parasitology). This receptor is primarily expressed in the nervous system and muscles of nematodes, where it facilitates neuromuscular transmission and coordinates locomotion (UniProt P49158). ACR-23 is the definitive molecular target for the amino-acetonitrile derivative (AAD) class of anthelmintics, specifically monepantel (Baur et al., 2015, PLOS Pathogens). When monepantel binds to the receptor, it acts as a potent agonist, causing the channel to remain open and leading to an exhaustive influx of cations (Rufener et al., 2010, PLoS Neglected Tropical Diseases). This overstimulation results in rapid muscle hypercontraction, spastic paralysis, and the eventual death of the parasite. Because the DEG-3 subfamily is absent in mammals, ACR-23 provides a high margin of safety and selectivity for treating helminth infections in livestock (Lecová et al., 2014, Parasitology Research). However, the emergence of resistance, often characterized by loss-of-function mutations or deletions in the acr-23 gene, remains a significant challenge in veterinary medicine.

Other names
MPTL-1Monepantel-sensitive receptor 1DEG-3 subfamily nicotinic acetylcholine receptor subunitacr-23
02

Mechanism of action

Agonist of the nematode-specific DEG-3 subfamily nicotinic acetylcholine receptor, causing persistent channel opening, depolarization, and spastic paralysis (Kaminsky et al., 2008).

03

Biological functions

Signal transductionNeuromuscular transmissionLocomotion
04

Disease associations

InfectionHelminthiasis
05

Safety considerations

Development of anthelmintic resistanceTarget specificity
06

Interacting drugs

Monepantel
07

Biomarkers

acr-23 gene deletionsacr-23 SNPs associated with monepantel resistance

Beyond the preview

Go deeper on Acetylcholine receptor subunit acr-23 (ACR-23) (ACR-23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetylcholine receptor subunit acr-23 (ACR-23) (ACR-23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call